ASTRAZEN — Astrazeneca Pharma India Share News
0.000.00%
Last trade - 00:00- IN₹210.84bn
- IN₹207.37bn
- IN₹22.76bn
Brief: Astrazeneca Pharma India Dec-Qtr PAT Falls
Media: AstraZeneca Pharma India working on vaccine to prevent and cure COVID - ET
Iran's daily COVID-19 deaths hit record high of 655
Brief: Astrazeneca Pharma India June-Quarter PAT Falls
Refinitiv Newscasts - Asia Insight: Indian shares steady ahead of cabinet reshuffle
Brief: Astrazeneca Pharma India Gets Notice Of Demand From National Pharmaceutical Pricing Authority
Brief: Astrazeneca Pharma India Terminates Distribution Agreement For Dapagliflozin With Abbott Healthcare
Brief: Astrazeneca Pharma India, Sun Pharma Enter Into Transition Supply Agreement For Dapagliflozin
Brief: Astrazeneca Pharma India March-Qtr PAT Rises
EU wants AstraZeneca to deliver 120 mln COVID vaccines by end-June
Five EU countries say focus should be on vaccine production, not patents (updated)
Brief: Astrazeneca Pharma India Gets Import, Market Permission From DCGI For Osimertinib Film Coated Tablets
EU's von der Leyen tells skittish Europeans: 'I'd take AstraZeneca vaccine'
Brief: Astrazeneca Pharma India Dec-Quarter PAT Falls
Michel says EU should consider legal means to secure promised vaccines
Brazil diplomats press to secure vaccine made in India, says Fiocruz
India's approval of homegrown vaccine criticised over lack of data (updated)
India's approval of homegrown vaccine criticised over lack of data
India gives final urgent-use approval to AstraZeneca and local COVID vaccines (updated)